Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Zamboni

Showing results (91-100 of 180) with videos related to

Pageof 18
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1997
Efficacy of systemic administration of irinotecan against neuroblastoma xenograftsJ Thompson, W C Zamboni, P J Cheshire, et al.
Molecular Pharmacology|November 21, 2007
Antitumor mechanisms of systemically administered epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neckSufi Mary Thomas, Michelene Jeter Ogagan, Maria L Freilino, et al.
Clinical and Translational Science|March 7, 2025
Evaluation of Innate Immune System, Body Habitus, and Sex on the Pharmacokinetics and Pharmacodynamics of Anetumab Ravtansine in Patients With CancerLi Chen, Andrew T Lucas, Aaron S Mansfield, et al.
The International Journal of Prosthodontics|March 18, 2010
Analysis of tooth enamel after excessive bleaching: a study using scanning electron microscopy and energy dispersive x-ray spectroscopyRodrigo O A Souza, Geraldo H L Lombardo, Sarina M B Pereira, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 7, 2007
Pitfalls of the application of microdialysis in clinical oncology: controversial findings with docetaxelW J Loos, W C Zamboni, F K Engels, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
Relationship between plasma exposure of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite and antitumor response in mice bearing human colon carcinoma xenograftsWilliam C Zamboni, Laura L Jung, Merrill J Egorin, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|July 30, 2013
Meta-analysis of inter-patient pharmacokinetic variability of liposomal and non-liposomal anticancer agentsRyan F Schell, Brian J Sidone, Whitney P Caron, et al.
ACS Applied Materials & Interfaces|April 8, 2020
Tumor Responsive and Tunable Polymeric Platform for Optimized Delivery of Paclitaxel to Treat GlioblastomaElizabeth G Graham-Gurysh, Kathryn M Moore, Allison N Schorzman, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 7, 2015
Evaluation of drug loading, pharmacokinetic behavior, and toxicity of a cisplatin-containing hydrogel nanoparticleMarc P Kai, Amanda W Keeler, Jillian L Perry, et al.
Gynecologic Oncology|June 27, 2015
Phase I study of intravenous (IV) docetaxel and intraperitoneal (IP) oxaliplatin in recurrent ovarian and fallopian tube cancerSarah E Taylor, Ruosha Li, Jennifer S Petschauer, et al.
Pageof 18

Showing results (91-100 of 180) with videos related to

Sort By:
Pageof 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1997
Efficacy of systemic administration of irinotecan against neuroblastoma xenograftsJ Thompson, W C Zamboni, P J Cheshire, et al.
Molecular Pharmacology|November 21, 2007
Antitumor mechanisms of systemically administered epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neckSufi Mary Thomas, Michelene Jeter Ogagan, Maria L Freilino, et al.
Clinical and Translational Science|March 7, 2025
Evaluation of Innate Immune System, Body Habitus, and Sex on the Pharmacokinetics and Pharmacodynamics of Anetumab Ravtansine in Patients With CancerLi Chen, Andrew T Lucas, Aaron S Mansfield, et al.
The International Journal of Prosthodontics|March 18, 2010
Analysis of tooth enamel after excessive bleaching: a study using scanning electron microscopy and energy dispersive x-ray spectroscopyRodrigo O A Souza, Geraldo H L Lombardo, Sarina M B Pereira, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 7, 2007
Pitfalls of the application of microdialysis in clinical oncology: controversial findings with docetaxelW J Loos, W C Zamboni, F K Engels, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
Relationship between plasma exposure of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite and antitumor response in mice bearing human colon carcinoma xenograftsWilliam C Zamboni, Laura L Jung, Merrill J Egorin, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|July 30, 2013
Meta-analysis of inter-patient pharmacokinetic variability of liposomal and non-liposomal anticancer agentsRyan F Schell, Brian J Sidone, Whitney P Caron, et al.
ACS Applied Materials & Interfaces|April 8, 2020
Tumor Responsive and Tunable Polymeric Platform for Optimized Delivery of Paclitaxel to Treat GlioblastomaElizabeth G Graham-Gurysh, Kathryn M Moore, Allison N Schorzman, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 7, 2015
Evaluation of drug loading, pharmacokinetic behavior, and toxicity of a cisplatin-containing hydrogel nanoparticleMarc P Kai, Amanda W Keeler, Jillian L Perry, et al.
Gynecologic Oncology|June 27, 2015
Phase I study of intravenous (IV) docetaxel and intraperitoneal (IP) oxaliplatin in recurrent ovarian and fallopian tube cancerSarah E Taylor, Ruosha Li, Jennifer S Petschauer, et al.
Pageof 18